Product Description
Tigecycline for injection is indicated in patients 18 years of age and older for the treatment of community-acquired bacterial pneumonia caused by susceptible isolates ofStreptococcus pneumoniae(penicillin-susceptible isolates), including cases with concurrent bacteremia,Haemophilus influenzae, andLegionella pneumophila.